Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Melanoma 2 Small Cell Lung Carcinoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Inoperable œsophageal Cancer 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Advanced Solid Tumors 1

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Inoperable œsophageal Cancer × Ipilimumab × Clear all

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡